Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RK-0202 for Oral Mucositis in Head and Neck Cancer
NCT00230191Phase 2Completed
- Sponsor
- RxKinetix
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of EN3285 in oral mucositis (OM), sponsored by RxKinetix. Started Jan 2003; status: completed.
02
Drugs
EN3285
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00230191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00230191.